Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) (CARES)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03363841
Recruitment Status : Recruiting
First Posted : December 6, 2017
Last Update Posted : September 1, 2020
Sponsor:
Information provided by (Responsible Party):
Scynexis, Inc.